| meta-analysis | Q815382 |
| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.EJPAIN.2008.03.012 |
| P8608 | Fatcat ID | release_pen2d5qjsbbiply6lxbyknopmm |
| P698 | PubMed publication ID | 18456524 |
| P5875 | ResearchGate publication ID | 5395447 |
| P2093 | author name string | Gerry Oster | |
| John Edelsberg | |||
| P2860 | cites work | Analgesic therapy in postherpetic neuralgia: a quantitative systematic review | Q21144723 |
| Gabapentin for acute and chronic pain | Q24246411 | ||
| Antidepressants for neuropathic pain | Q24246575 | ||
| Neuropathic pain: a practical guide for the clinician | Q24553796 | ||
| Tips for learners of evidence-based medicine: 1. Relative risk reduction, absolute risk reduction and number needed to treat | Q24564452 | ||
| An assessment of clinically useful measures of the consequences of treatment | Q28297274 | ||
| Measuring the accuracy of diagnostic systems | Q29614441 | ||
| The number needed to treat: a clinically useful measure of treatment effect | Q29619672 | ||
| Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review | Q30640178 | ||
| Critical review of oral drug treatments for diabetic neuropathic pain-clinical outcomes based on efficacy and safety data from placebo-controlled and direct comparative studies | Q30988464 | ||
| Opioids in chronic non-cancer pain: systematic review of efficacy and safety | Q31131499 | ||
| EFNS guidelines on neuropathic pain assessment | Q33199137 | ||
| Reporting number needed to treat and absolute risk reduction in randomized controlled trials | Q34130944 | ||
| Meta-analysis of effects and side effects of low dosage tricyclic antidepressants in depression: systematic review | Q34204924 | ||
| Duloxetine vs. placebo in patients with painful diabetic neuropathy | Q34422685 | ||
| A systematic review of antidepressants in neuropathic pain | Q34423548 | ||
| A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes | Q34450871 | ||
| Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis | Q34533581 | ||
| EFNS guidelines on pharmacological treatment of neuropathic pain. | Q34573607 | ||
| Clinical practice. Painful sensory neuropathy | Q35093145 | ||
| Core outcome measures for chronic pain clinical trials: IMMPACT recommendations | Q35994723 | ||
| Pharmacological treatment of peripheral neuropathic pain conditions based on shared commonalities despite multiple etiologies. | Q36015438 | ||
| Tips for learners of evidence-based medicine: 4. Assessing heterogeneity of primary studies in systematic reviews and whether to combine their results | Q36058222 | ||
| Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials | Q36171579 | ||
| Algorithm for neuropathic pain treatment: an evidence based proposal. | Q36280904 | ||
| Systemic administration of local anesthetics to relieve neuropathic pain: a systematic review and meta-analysis | Q36318844 | ||
| Management of neuropathic pain: translating mechanistic advances and evidence-based research into clinical practice | Q36339617 | ||
| Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens | Q39366709 | ||
| Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial | Q39377711 | ||
| Intrathecal methylprednisolone for intractable postherpetic neuralgia | Q39424571 | ||
| Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain | Q39436267 | ||
| Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale | Q40678235 | ||
| Using numerical results from systematic reviews in clinical practice | Q41461392 | ||
| Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study | Q43787190 | ||
| Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial | Q44198291 | ||
| Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects | Q45057234 | ||
| Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial | Q45185821 | ||
| P433 | issue | 1 | |
| P921 | main subject | neuropathic pain | Q2798704 |
| P304 | page(s) | 11-16 | |
| P577 | publication date | 2008-05-05 | |
| P1433 | published in | European Journal of Pain | Q4548992 |
| P1476 | title | Summary measures of number needed to treat: how much clinical guidance do they provide in neuropathic pain? | |
| P478 | volume | 13 |
| Q47816185 | A review of Neuropathic Pain: From Guidelines to Clinical Practice |
| Q45349219 | Advances in clinical research methodology for pain clinical trials |
| Q52595844 | Do the potential benefits outweigh the risks? An update on the use of ziconotide in clinical practice. |
| Q51498641 | Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders. |
| Q51509688 | General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry. |
| Q30537158 | Guidelines in the management of diabetic nerve pain: clinical utility of pregabalin |
| Q37699093 | Pregnancy suppresses neuropathic pain induced by chronic constriction injury in rats through the inhibition of TNF-α. |
| Q34074987 | Systematic review and meta-analysis of efficacy, safety, and tolerability data from randomized controlled trials of drugs used to treat postherpetic neuralgia |
Search more.